ARCLIZON Trademark

Trademark Overview


On Thursday, June 22, 2006, a trademark application was filed for ARCLIZON with the United States Patent and Trademark Office. The USPTO has given the ARCLIZON trademark a serial number of 78914040. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 14, 2010. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The ARCLIZON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of immunological diseases and disorders, heart and circulatory diseases, hypertension, cardiovascular diseases, urological diseases, gastrointestinal disorders, metabolic diseases, chronic peripheral arterial occlusive diseases, inflammatory diseases and disorders
arclizon

General Information


Serial Number78914040
Word MarkARCLIZON
Filing DateThursday, June 22, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 14, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2007

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of immunological diseases and disorders, heart and circulatory diseases, hypertension, cardiovascular diseases, urological diseases, gastrointestinal disorders, metabolic diseases, chronic peripheral arterial occlusive diseases, inflammatory diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 28, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Monday, June 14, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 14, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 13, 2009EXTENSION 5 GRANTED
Monday, October 12, 2009EXTENSION 5 FILED
Monday, October 12, 2009TEAS EXTENSION RECEIVED
Wednesday, April 15, 2009EXTENSION 4 GRANTED
Friday, April 3, 2009EXTENSION 4 FILED
Wednesday, April 15, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 3, 2009TEAS EXTENSION RECEIVED
Friday, August 29, 2008EXTENSION 3 GRANTED
Friday, August 29, 2008EXTENSION 3 FILED
Friday, August 29, 2008TEAS EXTENSION RECEIVED
Tuesday, March 4, 2008EXTENSION 2 GRANTED
Tuesday, March 4, 2008EXTENSION 2 FILED
Tuesday, March 4, 2008TEAS EXTENSION RECEIVED
Tuesday, October 16, 2007EXTENSION 1 GRANTED
Tuesday, October 16, 2007EXTENSION 1 FILED
Tuesday, October 16, 2007TEAS EXTENSION RECEIVED
Tuesday, May 15, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 20, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 31, 2007NOTICE OF PUBLICATION
Friday, December 29, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 29, 2006ASSIGNED TO LIE
Monday, December 11, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 7, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 6, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 6, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 27, 2006NON-FINAL ACTION E-MAILED
Monday, November 27, 2006NON-FINAL ACTION WRITTEN
Monday, November 27, 2006ASSIGNED TO EXAMINER
Wednesday, June 28, 2006NEW APPLICATION ENTERED IN TRAM